<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01543074</url>
  </required_header>
  <id_info>
    <org_study_id>CA122959</org_study_id>
    <nct_id>NCT01543074</nct_id>
  </id_info>
  <brief_title>Dietary Histone Deacetylase Inhibitors (HDAC)</brief_title>
  <official_title>Dietary Histone Deacetylase (HDAC) Inhibitors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas A&amp;M University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas A&amp;M University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot, three-week study will help scientists understand more about how the foods people
      eat can modify histone deacetylases, enzymes the body produces naturally. Broccoli sprout
      extract (BSE) and garlic oil are thought to modify these enzymes. The purpose of this study
      is to see if taking broccoli sprout extract alone, garlic oil alone, or broccoli sprout
      extract and garlic oil together, can decrease the action of histone deacetylase (HDAC) and
      turn on genes in white blood cells. There will be 80 people in this study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study participants attend a pre-study meeting either individually or with several other
      potential volunteers according to their preference. The study is described in detail and
      participants are given the opportunity to ask questions. If participants agree to
      participate, they will sign the consent form. Height and weight will be measured privately.

      Food diary forms will be distributed and taught how to use. A 4ml (1 tsp) blood sample will
      be drawn for a pre-study blood chemistry, CBC and thyroid tests. Samples for all clinical
      labs done during the study will be sent to Good Samaritan Hospital, a CLIA-certified
      laboratory, on a fee-for-service basis.

      The study MD will evaluate the lab results. If the tests are abnormal as determined by the
      study MD, the participant will be excluded from the study and advised to see their doctor for
      evaluation.

      Subjects will observe dietary restrictions starting one week before Day 1 of the study and
      continuing through Day 14 (total of 3 weeks). Dietary restrictions are listed on the last
      page of the diet recall forms.

      Women with negative urine pregnancy test on the morning of Day 1 will be enrolled in the
      study. About 20 ml fasting blood will be drawn on the morning of Day 1. Breakfast will be
      provided and 3 capsules given to swallow. (One capsule will be garlic oil or garlic oil
      placebo, the other two will be BSE or BSE placebo.) No eating or drinking (except water)
      until the next blood draws at 1,3 6 hours after breakfast.

      Participants will come to the study site for the next seven days to consume the standard
      breakfast and study capsules, or we may send the breakfast and study capsules home with
      participants for the weekend. Blood will be sampled immediately before breakfast on day 7 and
      again at 1, 3, 6, 24 and 48 hours later. We will provide a standardized lunch to all
      participants on Days 1 and 7. Additional blood draws will occur at the end of week 2 (i.e. on
      day 14 of the study). The study will end after 2 weeks.

      Participants will fill out a dietary recall form three random times during the study on two
      week days and one weekend day.

      Urine will be collected on the following schedule: Day 1, 0-3 hours, 3-6 hours, 6-12
      hours,12-24 hours, 24-48 hours; Day 7, 0-3 hours, 3-6 hours, 6-12 hours, 12-24 hours, 24-48
      hours. Total urine from each interval will be collected and pooled in separate containers. We
      will provide the proper containers for urine collection. Urine may be stored at room
      temperature.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor recruitment
  </why_stopped>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cmax of Sulforaphane and Its Metabolites in Blood</measure>
    <time_frame>Before breakfast (0 hours) and 1, 3 and 6 hours after breakfast &amp; pills on Days 1 &amp; 7, and before breakfast on Days 8, 9 and 14.</time_frame>
    <description>The levels of &quot;Sulforaphane and its metabolites (combined)&quot; in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. Cmax (mean +/- SD) values are shown in the &quot;Outcome Measure Data Table&quot;.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tmax of Sulforaphane and Its Metabolites in Blood</measure>
    <time_frame>Before breakfast (0 hours) and 1, 3 and 6 hours after breakfast &amp; pills on Days 1 &amp; 7, and before breakfast on Days 8, 9 and 14.</time_frame>
    <description>The levels of &quot;Sulforaphane and its metabolites (combined)&quot; in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. The time to achieve highest plasma concentration (Tmax) is shown in the &quot;Outcome Measure Data Table&quot;.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Histone Acetylation</measure>
    <time_frame>21 days</time_frame>
    <description>Change in histone acetylation</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Histone Deacetylase (HDAC) Activity</condition>
  <arm_group>
    <arm_group_label>BSE placebo &amp; garlic oil placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two BSE placebo capsules and one garlic oil placebo capsule per day for seven days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>garlic oil plus BSE placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>one garlic oil capsule plus 2 BSE placebo capsules per day for seven days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BSE plus garlic oil placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>two BSE capsules plus one garlic oil placebo capsule per day for seven days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BSE &amp; Garlic Oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>two BSE and one garlic oil capsule per day for seven days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>BSE placebo</intervention_name>
    <description>2 pills = 0 micromoles of Sulforaphane/day</description>
    <arm_group_label>BSE placebo &amp; garlic oil placebo</arm_group_label>
    <arm_group_label>garlic oil plus BSE placebo</arm_group_label>
    <other_name>Placebo for Broccoli Sprout Extract</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Garlic oil</intervention_name>
    <description>1 pill = 30 mg garlic oil/day</description>
    <arm_group_label>garlic oil plus BSE placebo</arm_group_label>
    <arm_group_label>BSE &amp; Garlic Oil</arm_group_label>
    <other_name>Schiff Super Garlic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BSE</intervention_name>
    <description>2 pills = 200 micromoles of Sulforaphane/day</description>
    <arm_group_label>BSE plus garlic oil placebo</arm_group_label>
    <arm_group_label>BSE &amp; Garlic Oil</arm_group_label>
    <other_name>Broccoli Sprout Extract</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Garlic Oil Placebo</intervention_name>
    <description>1 pill = 0 mg garlic oil/day</description>
    <arm_group_label>BSE placebo &amp; garlic oil placebo</arm_group_label>
    <arm_group_label>BSE plus garlic oil placebo</arm_group_label>
    <other_name>Placebo for Schiff Super Garlic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  age: 20 and older

          -  body mass index 19-30 kg/sq m

          -  willingness to maintain normal exercise and activity patterns

          -  willingness to avoid cruciferous vegetables and garlic and related foods (onion etc.)
             1 week before and 2 weeks during the trial for a total of 3 weeks

        Exclusion criteria:

          -  tobacco use within the past three months

          -  engaging in aerobic activity more than 6 hours per week

          -  being vegetarian or having other restrictive dietary requirements

          -  consuming &gt;3 alcoholic beverages/day or &gt;10 per week

          -  having history of diabetes or uremia or other known metabolic disease

          -  participating in another dietary study within the past three months

          -  for women, being pregnant or breastfeeding

          -  gastrointestinal diseases that could increase gut permeability, including Crohn's
             disease, ulcerative colitis, gastritis

          -  taking dietary supplements other than those given in the study

          -  abnormal liver function, CBC, or thyroid values

          -  individuals taking any drug or medication, prescription or over the counter, including
             Isoniazid, Saquinavir, Warfarin, Cyclosporine, Acetaminophen, Oxazepam, medications
             used for HIV/ AIDS, blood clotting, birth control pills, fish oil and medications
             metabolized by CYPs (CYP1A2, CYP2E1 and CYP3A4) during the dosing period of 1 week and
             48 h prior to and after dosing. Exceptions may be made by the study MD and the PI if
             in their opinion a medication will not interfere with the scientific validity of the
             study. The study MD will evaluate a medication on a case-by-case basis to determine
             that efficacy and safety are not adversely affected.

          -  Individuals who are known to have problems with blood clotting or increased bleeding,
             including hemophiliacs or anyone recently undergoing or recovering from a surgical
             procedure.

          -  soy or garlic allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roderick Dashwood, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas A&amp;M University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oregon State University</name>
      <address>
        <city>Corvallis</city>
        <state>Oregon</state>
        <zip>97331</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2012</study_first_submitted>
  <study_first_submitted_qc>March 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2012</study_first_posted>
  <results_first_submitted>June 1, 2015</results_first_submitted>
  <results_first_submitted_qc>August 10, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 10, 2015</results_first_posted>
  <last_update_submitted>August 10, 2015</last_update_submitted>
  <last_update_submitted_qc>August 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas A&amp;M University</investigator_affiliation>
    <investigator_full_name>Roderick Dashwood</investigator_full_name>
    <investigator_title>Director Center for Epigenetics &amp; Disease Prevention</investigator_title>
  </responsible_party>
  <keyword>HDAC</keyword>
  <keyword>histone acetylation</keyword>
  <keyword>broccoli sprout extract</keyword>
  <keyword>garlic oil</keyword>
  <keyword>PBMCs</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Histone Deacetylase Inhibitors</mesh_term>
    <mesh_term>Allyl sulfide</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>34 Subjects consented for the study at the Linus Pauling Institute clinic, Corvallis, Oregon during the period February, 2013 to November, 2013. However, only 23 who qualified the criteria in the pre-screen blood tests were selected for the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>BSE Placebo &amp; Garlic Oil Placebo</title>
          <description>Two BSE placebo capsules and one garlic oil placebo capsule per day for seven days
BSE placebo &amp; garlic oil placebo: see arm description
BSE &amp; Garlic Oil: see arm description</description>
        </group>
        <group group_id="P2">
          <title>Garlic Oil Plus BSE Placebo</title>
          <description>one garlic oil capsule plus 2 BSE placebo capsules per day for seven days
BSE placebo &amp; garlic oil placebo: see arm description
BSE plus garlic oil placebo: see arm description</description>
        </group>
        <group group_id="P3">
          <title>BSE Plus Garlic Oil Placebo</title>
          <description>two BSE capsules plus one garlic oil placebo capsule per day for seven days
garlic oil plus BSE placebo: see arm description
BSE &amp; Garlic Oil: see arm description</description>
        </group>
        <group group_id="P4">
          <title>BSE &amp; Garlic Oil</title>
          <description>two BSE and one garlic oil capsule per day for seven days
garlic oil plus BSE placebo: see arm description
BSE plus garlic oil placebo: see arm description</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>BSE Placebo &amp; Garlic Oil Placebo</title>
          <description>Two BSE placebo capsules and one garlic oil placebo capsule per day for seven days
BSE placebo &amp; garlic oil placebo: see arm description
BSE &amp; Garlic Oil: see arm description</description>
        </group>
        <group group_id="B2">
          <title>Garlic Oil Plus BSE Placebo</title>
          <description>one garlic oil capsule plus 2 BSE placebo capsules per day for seven days
BSE placebo &amp; garlic oil placebo: see arm description
BSE plus garlic oil placebo: see arm description</description>
        </group>
        <group group_id="B3">
          <title>BSE Plus Garlic Oil Placebo</title>
          <description>two BSE capsules plus one garlic oil placebo capsule per day for seven days
garlic oil plus BSE placebo: see arm description
BSE &amp; Garlic Oil: see arm description</description>
        </group>
        <group group_id="B4">
          <title>BSE &amp; Garlic Oil</title>
          <description>two BSE and one garlic oil capsule per day for seven days
garlic oil plus BSE placebo: see arm description
BSE plus garlic oil placebo: see arm description</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="7"/>
            <count group_id="B3" value="5"/>
            <count group_id="B4" value="6"/>
            <count group_id="B5" value="23"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.8" spread="14.1"/>
                    <measurement group_id="B2" value="29.9" spread="10.1"/>
                    <measurement group_id="B3" value="30.8" spread="17.2"/>
                    <measurement group_id="B4" value="33.7" spread="18.1"/>
                    <measurement group_id="B5" value="30" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cmax of Sulforaphane and Its Metabolites in Blood</title>
        <description>The levels of &quot;Sulforaphane and its metabolites (combined)&quot; in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. Cmax (mean +/- SD) values are shown in the &quot;Outcome Measure Data Table&quot;.</description>
        <time_frame>Before breakfast (0 hours) and 1, 3 and 6 hours after breakfast &amp; pills on Days 1 &amp; 7, and before breakfast on Days 8, 9 and 14.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BSE Placebo &amp; Garlic Oil Placebo</title>
            <description>Two BSE placebo capsules and one garlic oil placebo capsule per day for seven days
BSE placebo &amp; garlic oil placebo: see arm description
BSE &amp; Garlic Oil: see arm description</description>
          </group>
          <group group_id="O2">
            <title>Garlic Oil Plus BSE Placebo</title>
            <description>one garlic oil capsule plus 2 BSE placebo capsules per day for seven days
BSE placebo &amp; garlic oil placebo: see arm description
BSE plus garlic oil placebo: see arm description</description>
          </group>
          <group group_id="O3">
            <title>BSE Plus Garlic Oil Placebo</title>
            <description>two BSE capsules plus one garlic oil placebo capsule per day for seven days
garlic oil plus BSE placebo: see arm description
BSE &amp; Garlic Oil: see arm description</description>
          </group>
          <group group_id="O4">
            <title>BSE &amp; Garlic Oil</title>
            <description>two BSE and one garlic oil capsule per day for seven days
garlic oil plus BSE placebo: see arm description
BSE plus garlic oil placebo: see arm description</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax of Sulforaphane and Its Metabolites in Blood</title>
          <description>The levels of &quot;Sulforaphane and its metabolites (combined)&quot; in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. Cmax (mean +/- SD) values are shown in the &quot;Outcome Measure Data Table&quot;.</description>
          <units>micromoles/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">below limit of detection</measurement>
                    <measurement group_id="O2" value="NA">below limit of detection</measurement>
                    <measurement group_id="O3" value="0.92" spread="0.15"/>
                    <measurement group_id="O4" value="1.26" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Histone Acetylation</title>
        <description>Change in histone acetylation</description>
        <time_frame>21 days</time_frame>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Tmax of Sulforaphane and Its Metabolites in Blood</title>
        <description>The levels of &quot;Sulforaphane and its metabolites (combined)&quot; in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. The time to achieve highest plasma concentration (Tmax) is shown in the &quot;Outcome Measure Data Table&quot;.</description>
        <time_frame>Before breakfast (0 hours) and 1, 3 and 6 hours after breakfast &amp; pills on Days 1 &amp; 7, and before breakfast on Days 8, 9 and 14.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BSE Placebo &amp; Garlic Oil Placebo</title>
            <description>Two BSE placebo capsules and one garlic oil placebo capsule per day for seven days
BSE placebo: 2 pills = 0 micromoles of Sulforaphane/day
Garlic Oil Placebo: 1 pill = 0 mg garlic oil/day</description>
          </group>
          <group group_id="O2">
            <title>Garlic Oil Plus BSE Placebo</title>
            <description>one garlic oil capsule plus 2 BSE placebo capsules per day for seven days
BSE placebo: 2 pills = 0 micromoles of Sulforaphane/day
Garlic oil: 1 pill = 30 mg garlic oil/day</description>
          </group>
          <group group_id="O3">
            <title>BSE Plus Garlic Oil Placebo</title>
            <description>two BSE capsules plus one garlic oil placebo capsule per day for seven days
BSE: 2 pills = 200 micromoles of Sulforaphane/day
Garlic Oil Placebo: 1 pill = 0 mg garlic oil/day</description>
          </group>
          <group group_id="O4">
            <title>BSE &amp; Garlic Oil</title>
            <description>two BSE and one garlic oil capsule per day for seven days
Garlic oil: 1 pill = 30 mg garlic oil/day
BSE: 2 pills = 200 micromoles of Sulforaphane/day</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax of Sulforaphane and Its Metabolites in Blood</title>
          <description>The levels of &quot;Sulforaphane and its metabolites (combined)&quot; in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. The time to achieve highest plasma concentration (Tmax) is shown in the &quot;Outcome Measure Data Table&quot;.</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">below limit of detection</measurement>
                    <measurement group_id="O2" value="NA">below limit of detection</measurement>
                    <measurement group_id="O3" value="3" spread="0"/>
                    <measurement group_id="O4" value="3" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>BSE Placebo &amp; Garlic Oil Placebo</title>
          <description>Two BSE placebo capsules and one garlic oil placebo capsule per day for seven days
BSE placebo &amp; garlic oil placebo: see arm description
BSE &amp; Garlic Oil: see arm description</description>
        </group>
        <group group_id="E2">
          <title>Garlic Oil Plus BSE Placebo</title>
          <description>one garlic oil capsule plus 2 BSE placebo capsules per day for seven days
BSE placebo &amp; garlic oil placebo: see arm description
BSE plus garlic oil placebo: see arm description</description>
        </group>
        <group group_id="E3">
          <title>BSE Plus Garlic Oil Placebo</title>
          <description>two BSE capsules plus one garlic oil placebo capsule per day for seven days
garlic oil plus BSE placebo: see arm description
BSE &amp; Garlic Oil: see arm description</description>
        </group>
        <group group_id="E4">
          <title>BSE &amp; Garlic Oil</title>
          <description>two BSE and one garlic oil capsule per day for seven days
garlic oil plus BSE placebo: see arm description
BSE plus garlic oil placebo: see arm description</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination (23/80) due to small numbers of subjects recruited.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Rod Dashwood</name_or_title>
      <organization>Institute of Biosciences and Technology, Texas A&amp;M Health Science Center, Houston TX</organization>
      <phone>7136777806</phone>
      <email>rdashwood@ibt.tamhsc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

